Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark

Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark is a combination medication used in the treatment of HIV infection. This oral medication combines three active ingredients to help manage the virus.

Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark is primarily used in the management of HIV infection. This combination therapy is designed to reduce the amount of HIV in the body, helping to improve immune function and reduce the risk of HIV-related complications. The medication is often prescribed as part of a comprehensive treatment plan that includes other medications and lifestyle changes.

Common effects of Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark may include dizziness, nausea, and headache. Some individuals may experience changes in body fat distribution, such as increased fat in the upper back and decreased fat in the legs, arms, and face. It is important to discuss any persistent or severe side effects with a healthcare provider.

Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark should be used with caution in individuals with a history of liver or kidney disease. Regular monitoring of liver and kidney function is recommended. This medication should not be used by individuals who are allergic to any of its components. Pregnant women should consult their healthcare provider before using this medication.

Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark may interact with other medications, including those used to treat infections, seizures, and heart conditions. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be avoided while using this medication, as it may increase the risk of side effects.